We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INBS market cap is 5.78M. The company's latest EPS is USD -4.9502 and P/E is -0.46.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 627k | 574k | 483k | 906k | 917k |
| Operating Income | -2.13M | -6.54M | -3.08M | -2.53M | -1.99M |
| Net Income | -421k | -6.34M | -2.66M | -2.43M | -1.97M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 189k | 1.98M | 437k | 2M |
| Operating Income | -6.73M | -2.71M | -5.71M | -8.34M | -12.6M |
| Net Income | -7.34M | -3.14M | -7.04M | -8.31M | -10.63M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.05M | 10.67M | 10.36M | 8.7M | 8.83M |
| Total Liabilities | 7.79M | 4.74M | 6.67M | 7.46M | 5.67M |
| Total Equity | 10.26M | 5.93M | 3.69M | 1.24M | 3.15M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.33M | 2.48M | 21.86M | 12.35M | 10.36M |
| Total Liabilities | 6.31M | 7.69M | 6.85M | 5.81M | 6.67M |
| Total Equity | -3.98M | -5.22M | 15.01M | 6.55M | 3.69M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.28M | -6.79M | -7.38M | -1.31M | -4.18M |
| Investing | -686k | -512k | -694k | N/A | -56k |
| Financing | -328k | 1.39M | 1.44M | N/A | 3.79M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.58M | -499k | -11.3M | -3.36M | -7.38M |
| Investing | N/A | -14k | N/A | -880k | -694k |
| Financing | 5.32M | 734k | 23.4M | N/A | 1.44M |
| Market Cap | 5.78M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 2.48 |
| Price to Cash Ratio | 3.21 |
| Price to Book Ratio | 1.34 |
| Dividend Yield | - |
| Shares Outstanding | 2.15M |
| Average Volume (1 week) | 90.05k |
| Average Volume (1 Month) | 71.59k |
| 52 Week Change | -92.35% |
| 52 Week High | 44.88 |
| 52 Week Low | 2.16 |
| Spread (Intraday) | 0.38 (14.39%) |
| Company Name | Intelligent Bio Solutions Inc |
| Address |
2055 limestone road wilmington, delaware 198085539 |
| Website | https://www.gbs.inc |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
